Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19.
Sci Rep
; 12(1): 5207, 2022 03 25.
Article
in En
| MEDLINE
| ID: mdl-35338216
Full text:
1
Database:
MEDLINE
Main subject:
Enoxaparin
/
COVID-19 Drug Treatment
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Year:
2022
Type:
Article